Global Radiopharmaceutical Market By Product Type (SPECT Radioisotopes, PET Radioisotopes) And By End-Users/Application (Oncology, Cardiology) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

Abstract Global Radiopharmaceutical Market is accounted for xx USD million in 2019 and is expected to reach xx USD million by 2026 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global Radiopharmaceutical market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. Radiopharmaceutical Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2019 to 2026; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis. By geography, this market has been segregated into five regions with revenue and growth rate of Radiopharmaceutical from 2013 to 2026, • North America (U.S., Canada, Mexico) • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS) • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) • Latin America (Brazil, Rest of L.A.) • Middle East And Africa(Turkey, GCC, Rest of Middle East) The major players operating into Radiopharmaceutical Market include: Bayer Triad Isotopes Lantheus GE Healthcare Mallinckrodt Eli Lilly Bracco Imaging SIEMENS Navidea Nordion IBA Group Jubilant Pharma This report segments the Global Radiopharmaceu ...
Chapter 1 Industry Overview 1.1 Radiopharmaceutical Market Overview 1.1.1 Radiopharmaceutical Product Scope 1.1.2 Market Status and Outlook 1.2 Global Radiopharmaceutical Market Size and Analysis by Regions (2014-2019) 1.2.1 North America Radiopharmaceutical Market Status and Outlook 1.2.2 EU Radiopharmaceutical Market Status and Outlook 1.2.3 Japan Radiopharmaceutical Market Status and Outlook 1.2.4 China Radiopharmaceutical Market Status and Outlook 1.2.5 India Radiopharmaceutical Market Status and Outlook 1.2.6 Southeast Asia Radiopharmaceutical Market Status and Outlook 1.3 Global Radiopharmaceutical Market Segment by Types (2014-2025) 1.3.1 Global Radiopharmaceutical Revenue and Growth Rate Comparison by Types (2014-2025) 1.3.2 Global Radiopharmaceutical Revenue Market Share by Types in 2018 1.3.3 SPECT Radioisotopes 1.3.4 PET Radioisotopes 1.3.5 Other Diagnostic Radioisotopes Others 1.4 Radiopharmaceutical Market by End Users/Application 1.4.1 Global Radiopharmac ...
7135

8758

OUR CLIENT